ChemicalBook > CAS DataBase List > Duloxetine

Duloxetine

Product Name
Duloxetine
CAS No.
116539-59-4
Chemical Name
Duloxetine
Synonyms
DULOXETIN;DULOXETINE HCI;DULOXETINE-D3;(S)-DULOXETINE;(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1-amine;CS-559;DULOXETINE;(+)-Duloxetine;Duloxetine Hcl(S);Duloxetine, >=99%
CBNumber
CB8670379
Molecular Formula
C18H19NOS
Formula Weight
297.41
MOL File
116539-59-4.mol
More
Less

Duloxetine Property

Boiling point:
466.2±40.0 °C(Predicted)
Density 
1.158±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
Soluble in DMSO
pka
10.02±0.10(Predicted)
BCS Class
2
InChI
InChI=1/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/s3
InChIKey
BFFSMCNJSOPUAY-VOPAOICTNA-N
SMILES
C1(=CC=CS1)[C@H](CCNC)OC1=CC=CC2=CC=CC=C12.Cl |&1:5,r|
EPA Substance Registry System
2-Thiophenepropanamine, N-methyl-?-(1-naphthalenyloxy)-, (?S)- (116539-59-4)
More
Less

Safety

Hazardous Substances Data
116539-59-4(Hazardous Substances Data)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Matrix Scientific
Product number
094812
Product name
(S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine
Purity
95+%
Packaging
1g
Price
$135
Updated
2021/12/16
Matrix Scientific
Product number
094812
Product name
(S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine
Purity
95+%
Packaging
5g
Price
$360
Updated
2021/12/16
Biorbyt Ltd
Product number
orb146144
Product name
Duloxetine
Purity
>98%
Packaging
100mg
Price
$414.8
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
RDL0017905
Product name
DULOXETINE-D3
Purity
95.00%
Packaging
5MG
Price
$504.27
Updated
2021/12/16
Biorbyt Ltd
Product number
orb146144
Product name
Duloxetine
Purity
>98%
Packaging
250mg
Price
$615.4
Updated
2021/12/16
More
Less

Duloxetine Chemical Properties,Usage,Production

Uses

Antidepressant.

Definition

ChEBI: (S)-duloxetine is a duloxetine. It is an enantiomer of a (R)-duloxetine.

brand name

Cymbalta (Lilly).

General Description

Duloxetine (Cymbalta) is a newer antidepressant. It islargely like venlafaxine, which is an SNERI (selective norepinephrinereuptake inhibitor).

Pharmacokinetics

Duloxetine appears to be fairly well absorbed after oral doses, with peak plasma levels in 6 to 10 hours and linear pharmacokinetics. The drug is extensively metabolized in the liver to active metabolites, with 72% of an oral dose primarily excreted in the urine as conjugated metabolites and up to 15% appearing in the feces.
N-demethylation to an active metabolite (CYP2D6) and hydroxylation of the naphthyl ring (CYP1A2) at either the 4-, 5-, or 6-positions are the main metabolic pathways for duloxetine. Its metabolites are primarily excreted into the urine as glucuronide, sulfate, and O-methylated conjugation products. The major metabolites found in plasma also were found in the urine. Preclinical data for 4-hydroxyduloxetine suggests it has a similar pharmacological profile to duloxetine, with selective inhibition of SERT but less activity at the NET.

Clinical Use

Duloxetine has been approved for the treatment of depression and diabetic peripheral neuropathic pain. It is another analogue in the line of fluoxetine-based products from Lilly, in which the phenyl and phenoxy groups of fluoxetine have been respectively replaced with the benzene isostere, thiophene, and a naphthyloxy group (previously described under fluoxetine). Duloxetine exhibits dual inhibition with high affinity for the SERTs and NETs, with a five times preferential inhibition of the SERT. Duloxetine appears to be a more potent in vitro blocker of SERTs and NETs than venlafaxine. In humans, duloxetine has a low affinity for the other neuroreceptors, suggesting low incidence of unwanted adverse effects.

Synthesis

Reaction of 2-acetylthiophene with paraformaldehyde and dimethylamine in ethanol gives 3-(dimethylamino)-1-(2-thienyl)- 1-propanone, which is enantioselectively reduced with a 2:1 complex of (2R,3S)-4-(dimethylamino)- 3-methyl-1,2-diphenyl-2-butanol and LiAlH4 in toluene to yield (S)-3-(dimethylamino)- 1-(2-thienyl)-1-propanol. The condensation of (S)-3-(dimethylamino)-1-(2- thienyl)-1-propanol with 1-fluoronaphthalene catalyzed by NaH in DMSO affords the corresponding naphthyl ether (S)-N,N-dimethyl-3- (naphthalen-1-yloxy)-3-(thiophen-2-yl)propan- 1-amine, which is finally monodemethylated with 2,2,2-trichloroethyl chloroformate and zinc in toluene and treated with oxalic acid .

Drug interactions

Potentially hazardous interactions with other drugs
Antibacterials: metabolism inhibited by ciprofloxacin - avoid.
Anticoagulants: possibly increased risk of bleeding with dabigatran.
Other CNS medication: enhanced effect.
Antidepressants: avoid with MAOIs, moclobemide, St John’s wort, tryptophan, venlaflaxine, amitriptyline, clomipramine and SSRIs due to increased risk of serotonin syndrome; increased risk of side effects with tricyclic antidepressants; fluvoxamine decreases the clearance of duloxetine by 77% - avoid; possible increased risk of convulsions with vortioxetine.
Antimalarials: avoid with artemether/lumefantrine and piperaquine with artenimol.
Dapoxetine: avoid concomitant use.
Methylthioninium: risk of CNS toxicity - avoid if possible.

Metabolism

Duloxetine is extensively metabolised and the metabolites are excreted principally in urine. Both cytochromes P450-2D6 and 1A2 catalyse the formation of the two major metabolites, glucuronide conjugate of 4-hydroxy duloxetine and sulphate conjugate of 5-hydroxy, 6-methoxy duloxetine. Based upon in vitro studies, the circulating metabolites of duloxetine are considered pharmacologically inactive

Duloxetine Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Duloxetine Suppliers

Sree Rayalaseema Alkalies & Allied Chemicals Ltd
Tel
--
Fax
--
Email
sales2@picopen.com
Country
Japan
ProdList
182
Advantage
78
More
Less

View Lastest Price from Duloxetine manufacturers

Qingdao RENAS Polymer Material Co., Ltd.
Product
Duloxetine 116539-59-4
Price
US $0.00/kg
Min. Order
20kg
Purity
99%
Supply Ability
20 tons
Release date
2024-10-15
Shanghai Chinqesen Biotechnology Co., Ltd.
Product
Duloxetine 116539-59-4
Price
US $40.00-20.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
2000000
Release date
2023-10-25
Hebei Yalin Technology Co., Ltd
Product
Cymbalta 116539-59-4
Price
US $20.00-9000.00/KG
Min. Order
10KG
Purity
99.99%
Supply Ability
90000KG
Release date
2023-08-29

116539-59-4, DuloxetineRelated Search:


  • DULOXETINE
  • DULOXETINE-D3
  • (S)-DULOXETINE
  • DULOXETIN
  • (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1-amine
  • N-Methyl-gama-(1-naphthalenyloxy)-2-thiophenepropanamine
  • DULOXETINE HCI
  • Duloxetine & Intermediates
  • N-methyl-3-(1-naphthalenyloxy)-3-thiophen-2-yl-1-propanamine hydrochloride
  • CS-559
  • methyl-[(3S)-3-(1-naphthyloxy)-3-(2-thienyl)propyl]amine
  • (3R)-N-methyl-3-(naphthalen-1-yloxy)-3-thiophen-2-ylpropan-1-amine
  • (S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-aMine
  • Duloxetine Hcl(S)
  • Duloxetine, >=99%
  • Methyl[(3S)-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]aMine
  • 2-Thiophenepropanamine, N-methyl-γ-(1-naphthalenyloxy)-, (γS)-
  • Duloxetine USP/EP/BP
  • (+)-Duloxetine
  • Raw Powder API Duloxetine
  • DuloxetinehclQ: What is Duloxetinehcl Q: What is the CAS Number of Duloxetinehcl Q: What is the storage condition of Duloxetinehcl Q: What are the applications of Duloxetinehcl
  • Duloxetine ((S)-Duloxetine
  • 116539-59-4
  • 1165399-59-4
  • C18H18ONSHCL
  • C18N19NOS
  • C18H19NOS
  • API
  • ACTIVE PHARMACEUTICAL INGREDIENTS